Muscarinic Receptor Antagonist,
Showing 1 - 25 of 9,958
A Retrospective rEal-life daTa Study to Assess exaceRbations and
Completed
- COPD
- COPD Exacerbation
-
Thessaloniki, GreecePapanikolaou Hospital of Thessaloniki
Sep 7, 2022
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Multiple Sclerosis Trial in London (PIPE-307)
Completed
- Multiple Sclerosis
-
London, United KingdomHammersmith Medicines Research
Oct 4, 2022
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1
Recruiting
- Schizophrenia
- +2 more
- 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 16, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
PTSD Trial in San Francisco (CORT108297, Placebo)
Not yet recruiting
- PTSD
- CORT108297
- Placebo
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
COPD Trial in Llanelli (Any LABA/LAMA)
Completed
- Chronic Obstructive Pulmonary Disease
- Any LABA/LAMA
-
Llanelli, Carmarthenshire, United KingdomPrince Philip Hospital
Aug 2, 2022
Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)
Not yet recruiting
- Renal Cell Carcinoma
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)
Not yet recruiting
- Depressive Disorder, Major
- Anxiety Disorder
- Nociceptin Receptor Antagonist
- Aversive stimuli
- (no location specified)
Nov 3, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)
Recruiting
- Cardiovascular Diseases
- Vascular Dilation
- Ifetroban Sodium
- Placebo
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
Feb 16, 2022
Steatohepatitis, Nonalcoholic Trial in Shibin Al Kawm (Control group, Montelukast group)
Completed
- Steatohepatitis, Nonalcoholic
- Control group
- Montelukast group
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Medicine
Mar 15, 2022
Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise
Active, not recruiting
- Exercise
- Histamine
- Placebo: Placebo + exercise training.
- +2 more
-
Ghent, Oost-Vlaanderen, BelgiumDepartment of movement and sports sciences, Ghent University, Be
Nov 8, 2022